BAL PHARMA
Back to Income Statement
|
BAL PHARMA Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹30 Cr | ₹31 Cr | ₹25 Cr | ₹24 Cr | ₹25 Cr |
What is the latest Operating Profit of BAL PHARMA ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹30 Cr |
| Mar2024 | ₹31 Cr |
| Mar2023 | ₹25 Cr |
| Mar2022 | ₹24 Cr |
| Mar2021 | ₹25 Cr |
How is Operating Profit of BAL PHARMA Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹30 Cr | -3.80 | |
| Mar2024 | ₹31 Cr | 22.52 | |
| Mar2023 | ₹25 Cr | 5.30 | |
| Mar2022 | ₹24 Cr | -2.70 | |
| Mar2021 | ₹25 Cr | - | |
Compare Operating Profit of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹138.5 Cr | -1.8% | 8.8% | -12% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,794.0 Cr | 1.7% | -2.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,956.0 Cr | 2% | -2.2% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,820.0 Cr | -1.8% | -0.1% | 36.7% | Stock Analytics | |
| CIPLA | ₹109,370.0 Cr | -2% | -3.3% | -9.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,133.0 Cr | -0.6% | -3.8% | -6.9% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -1.8% |
8.8% |
-12% |
| SENSEX | 1.7% |
2.1% |
-6% |
You may also like the below Video Courses